Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
(Year: 2014)
  • Print
  • PDF
  • Embed

    Copy the following code and paste it into your website in order to display the current report.

  • Download to Excel
  • Download to PowerPoint

Customize Report

    • YEAR:
    • Region Type:

      • FOOTNOTES:
      • PSA screening rates are not adjusted; because the measure is already restricted by age and sex, statistical adjustments to correct for underlying population differences are not relevant.

      • The denominator consisted of male Medicare enrollees age 75-99 on January 1, 2012 who were eligible for Medicare Parts A and B and not enrolled in risk-bearing HMOs at any time during the year. Excluded from the analysis were men who had a PSA test for a presumed screening indication, men who had any history of prostate disease (prostate cancer, prostate surgery, or diagnosis of elevated PSA in the prior three years), and men who had prostate cancer-like symptoms in the three months before a PSA test based on diagnostic codes billed on visits and hospitalizations.

      • PSA screening was defined as any, but only one occurrence per patient during 2012 of CPT codes G0103 and 84153.


© 2018 The Trustees of Dartmouth College | 35 Centerra Parkway, Lebanon, NH 03766 | (603) 653-0800

The Dartmouth Atlas of Health Care is based at The Dartmouth Institute for Health Policy and Clinical Practice and is supported by a coalition of funders led by the Robert Wood Johnson Foundation, including the WellPoint Foundation, the United Health Foundation, the California HealthCare Foundation, and the Charles H. Hood Foundation.